A. Ari Hakimi

(Cell 179, 964–983.e1–e31; October 31, 2019) In the originally published version of this article, Daniel Geiszler's last name was misspelled. This error has now been corrected in the article online. Integrated Proteogenomic Characterization of Clear Cell Renal Cell CarcinomaClark et al.CellOctober 31, 2019In BriefComprehensive proteogenomic characterization in 103 treatment-naive clear cell renal cell carcinoma patient samples highlights tumor-specific alterations at the proteomic level that are unrevealed by transcriptomic profiling and proposes a revised subtyping scheme based on integrated omics analysis. Full-Text PDF Open Access

<p>PDF File - 74K, CSS by mutation type (missense vs truncating) in the MSKCC and TCGA cohorts.</p>

<p>PDF File - 106K, MSKCC mutation combination cancer specific survival curves.</p>

<p>PDF File - 111K, TCGA mutation combination cancer specific survival curves.</p>

<p>PDF File - 51K, Fold change in mutation (%) frequency for 3p TSGs by size (TCGA).</p>